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T he effect of UV irradiation on H T L V -Ill was quantita-
tively studied to evaluate the dosage of UV irradiation 
w hich inactiva tes the virus for steriliza tion of blood prod-
ucts and fo r laborato ry decontamin ation. In order to es-
timate the bio logic activity and quantitation of the virus, 
induction o f HTLV-Ill-specifi c antigens and inhibition of 
D NA synthesis in MT-4 cells infected by UV-irradiated 
HT LV -III were detected by indirect immunoflu orescence 
technique and proliferation assay usin g [3Hlthymidine up-
take, respectivel y. Furthermore, plaque-fo rming assay was 
performed to count the infectious viral particles. Results 
T he etio. logic agent of th e acquired immune defi Cienc.y synd ro m e (AI DS) is a newly recognized re trovirus ca lled human T -lympho tro pic virus type III (HTL V-III ) f1 J, lymphadenopath y-associated virus (LA V) [2], o r AIDS-associated retrovirus (AH.V) [3J. T he v irus 
is frequentl y isolated fro m patients w ith AI DS o r AIDS-related 
complex [4]. T he prevalence o f antibodies is high in th ose in fec ted 
o r at hi gh ri sk, but low in hea lth y controls [5-8]. Perso ns with 
hem ophilia arc thought to be at hi gh risk fo r the development of 
A IDS, since antibodies to H T L V- III / LA V have been found in the 
maj o rity of these persons w ho had received clo tting facto r con-
centrates [9-11 J. It is urgent ~o discover the means w hich w ill 
d irectl y inac tiva te the H TL V -III / LA V in blood products befo re 
they are administered to patients. Man y compounds are now 
being in ves tigated for their direct effects on the virus itself[1 2-1 4]. 
In attempting to evaluate the effects, however, the lack of quan-
ti tati ve assay systems was the main prob lem in accurately as-
sessing the am ount of the bio logica ll y ac ti ve virus. 
Previo usly, we repo rted that HT L V-III /LA V effi cientl y infects 
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showed that HT L V -III w as completely inactiva ted by 5000 
J/m2 UV irradiation. C loned UV-irradiated HTLV-IlJ (UV-
1) was obtained from a pl aque that was formed by 2000 
J/m2 UV-irradiated virus. When MT-4 cells were infected 
by the clone UV -1 , ballooning degenera tion o f cells was 
predominantly induced. T hese ballooning cells were not 
usually observed in MT -4 cells infected by unirradiated 
HT L V-III. The resistance to UV was not different between 
clone UV-1 and unirradiated HTLV-III. J Invest D erma tol 
87:239-243, 1986 
and propagates in a large number of HT L V-I , m ost probably a 
causa ti ve agent of adult T -cell leu kemia-carrying cell lines [15], 
such as M T -4 [1 6]. As a result, infected cells showed rem arkable 
cytopathic effect (CPE) leading to the inability of further passage 
of the cells [1 7]. Subsequentl y, we also developed quantitative 
assay sys tems fo r HTL V-III , using M T-4 cells [1 8], such as the 
plaqu e-inducti on and proliferation assay. In th e present study, 
we attempted to evaluate th e effec t of UV irradiation on the 
infecti vity of HT LV- IIJ by using these accurate assay sys tem s. 
O ur qu antitati ve studies revealed that UV irradiation inactivated 
the infectiv ity of HT L V-Ill at a dosage of 5000 J / m2 . 
M ATERJALS AN D METH O D S 
Virus Preparation and Treatment of the Virus by UV 
Irradiation For viral preparation, M olt-4/H T L V -.I1I cell sus-
pension was cultured for 4 days at 37°C in a CO2 incubato r. After 
spinning down the cells at 400 g fo r 10 min , supern atant was 
filtrated through a 0.22-/-,m Millipore membrane. O ne m illiliter 
of viral so lution in un covered 35-mm plastic dishes in an ice bath 
were irradiated by a UV lamp (Toshiba , T okyo , Japan) at dosages 
of 100, 200, 500, 1000, 2000, and 5000 J / m 2 . Then , the viral 
solution was diluted to one-tenth w ith fres h medium [RPMI 1640 
supplem ented w ith 10% decomplemented fetal calf senjm (FC S), 
100 I U / ml penicillin, and 100 /-,g / ml streptom ycin]. The intensity 
of the UV lamp was measured by a UV intensity m eter w ith a 
filter fo r 254 nm (Ultravio let Products Inc., San Ga briel , Cali-
fo rnia) before experiments were started . 
Immunofluorescence (IF) Method MT -4 cell s were adjusted 
to a concentration of 1 x 106 cells/ ml and 1 ml of the cell sus-
pension was mixed with the sa me volume of UV -irradiated and 
unirradiated virus. T he M T -4 cells infected by UV -irradiated 
HT L V-III were incubated at 37°C in a C O 2 incubato r. C ulture 
fluid w as changed on day 4 after infection. O n days 3, 5, and 7 
after infection, cells were smeared , d ried , and fi xed w ith cold 
methano l fo r 3 min . Fixed cells were then incubated w ith 1 :1000 
dilu ted human anti-HTL V-Ill- positi ve serum (IF titer ; 1 :4096) fo r 
30 min at 37°C. T hen, the preparation was washed fo r 15 min 
w ith phos phate- buffered saline (PBS). The flu o rescein isothio-
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cyan ate- conju gated antihuman IgG (Dako patts A/S, Co pen-
hagen , Denmark) was appli ed , in cubated fo r 30 min at 37"C, and 
washed aga in w ith PB S. The flli o rescent cells were exa min ed 
under a flu o rescent microsco pe and th e pe rcentage of IF-positi ve 
cell s was ca lculated. 
Proliferation Assay MT -4 cells w ere adjusted to 1 x 10" cells/ml 
and a 50-ILl aliqu o t o f cell suspension and th e sa m e volume of 
UV -irradiated o r unirradiated virus w as pl aced into each well o f 
a 96- well fl at':'bo ttom mi cro titer pl ate (Cornin g, N ew York , N ew 
Yo rk) . On th e 3 rd day after in oculati on of the virLl s, 100 ILl o f 
fresh m edium were dro pped into each w ell. The cells we re in-
cubated at 37°C in a CO2 incubato r fo r 5 days with 1 ILC i /we ll 
of [3H]th y midine (N ew Eng land Nuclear , Boston , M assachu-
setts) present fo r th e las t 18 h . C ultures were harves ted onto g lass 
fiber paper and [JH]thymidine uptake w as determined by a liquid 
scintillati on co unter. All ex perim ents were ca rried out in tripli-
ca te. Standard deviations of each ex perim ent we re less th an 5% 
o f th e m eail cpm . 
P laque-Forming Assay T o make an MT-4 cell-mono la yer on 
culture vessels, 1ml o f 50 ILg/ml ofp o lY- L-l ys ine (PLL; M .. 90,OOO, 
Sig m a C hemical Co. , St. Louis, Missouri ) were dropped o nto 
35-mm polys tyrene tissue culture dishes (Falcon, Oxnard , Ca li-
fo rnia). T he dishes w ere incubated fo r 1 h at roo m temperature. 
Then, PLL-coated dishes were was hed 3 tim es w ith PB S. O ne 
and one-half milliliters of 150 x 104/ ml o fMT-4 cell s we re then 
added into each PLL-coated dish and in cubated fo r 1 h at roo m 
temperature. The dishes were gentl y washed twice w ith PB S to 
rem ove unbound cell s. Then, 100 ILl of UV-ir ra di ated or unir-
radIated viral preparation w as slowly added to the dishes and 
in cubated fo r 1 h at roo m temperature. After adso rptio n of the 
virus, 1 ml o f the Aga rose overl ay mediulll consistin g of RPMI 
1640 m edium w ith 10% FC S, antibi o ti cs, and 0.6% Aga rose (Sea 
Pl aque Aga rose, M arine C olloid Corp ., Rockl and, M ain e) was 
po ured into each dish. The dishes were in cubated in a CO2 in-
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Figure 1. Appea rance of virus-specific antigens in UV-irradiated and 
un irradiated HTL V -III-infected MT -4. More than 500 ce lls were counted 
and percentage of IF-positive cells was calculated on 3, 5, and 7 days after 
infection. Control (e --e ), 100 ) l m 2 (A--A), 200 ) l m 2 (A- - - A), 
500 ) l m 2 (A- . - A), 1000 J/ m 2 (6 - 6),2000 J/m 2 (6- - -6), and 5000 
) l m 2 (6- · -6) UV- irradiated HTLV-III infected MT -4 and uninfccted 
MT-4 (0 -0). 
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Figure 2. Viral-induced cell dam age. O n days 3, 5, and 7 after infection, 
ce lls were counted in a hemocytometer under mi croscopy by the trypan 
blue exclusion method. Control (e--e), 100 ) l m 2 (A--A), 200 
) l m 2 (A- - - A), 500 ) l m 2 (A-· - A), 1000 ) l m 2 (6- 6), 2000 J/m 2 
(6- - - 6), and 5000 ) l m 2 (6- . - 6) UV-irradia ted HTLV-III-infected 
MT-4 and uninfected MT-4 (0 - - 0 ). 
cubato r at 37°C fo r 3 days and 1 ml o f Aga rose ove rl ay m edium 
containin g neutral red was added . The di shes we re in cubated at 
37"C fo r 3 m o re days and visible plaques were co unted . 
RES ULTS 
Effects of UV Irradiation on the Virus Infectivity Detected 
by HTL V -III-Specific Antigen Induction and Cell 
Damage T o evalu ate the infectivity of the irradiated virus, 
ex pression of HTL V -Ill-specifi c anti gens was assessed b y IF in 
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DILUTION OF VIRUS UV DOSE (X10'.ltn') 
Figure 3. Effect of UV irradiation on the virus infectivity (B ) detected 
by J3H)thymidine uptake mcthod. A, viral dose-response curve. Dilution 
1 of the virus was used fo r the in acti va tion ex pcriment in (B). Incorpo-
ration of J3HJth ymidin c in in fec ted MT-4 was determined 5 days after 
infec tion. A, Uninfectcd MT-4 (apm circles), HT LV-III-infected MT-4 
(so /id circles). 
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infected MT-4 cells (Fig 1). The llllInber of IF-pos iti ve cells ex-
presses the amount of biological ly active virus [1 7]. O n th e 7th 
day after infection, about 90% o f the IF-positi ve cell s were de-
tectable in both unirradiated and 1 00 J /m ~ UV -irradiated HTL V-
III-infected MT-4 cell s. At this point in time, 67, 59, and 49% 
o f IF-positi ve cells were detected in MT-4 cells infected by 200 
J1m~, 500J/m2 , and 1000J/m2 UV-irradiated viruses, respectively. 
Moreover, 2000 Jlm ~ UV-irradiated virus-infected MT-4 cells 
showed only 4% of the IF-positi ve cell s and 5000 J/m2 UV-
irradiated virus-infected cells showed absolutely no IF-positive 
cells. 
Virus-indu ced cell damage was determined by the trypan blue 
dye exclusion method . O n the 7th day after in fec tion, ncarl y 90% 
of infected cells were dead when HTLV-1I1 was trea ted by 100 
J/m2 of UV irradiation. However, 'cell damage was lo wcr than 
10% in 2000 and 5000 Jlm~ UV -irradiated virus-infected MT-4 
cells as well as uninfected ce lls (Fig 2) . 
Inhibition of UV-Irradiated Virus on DNA Synthesis in 
MT-4 Cells To furth er co'nfirm th e inactivation o f the vir'us by 
UV irradiation, a proliferation assay was perform cd. HTL V-IIl-
induced C PE is linked to the appearance of viral anti gens which 
are followed by the inhibition of DNA synthesis in HTLV-Ill -: 
infected MT -4 cells [14]. Fig 3A demonstrates that uninfectcd 
MT-4 cells showed over 300,000 cpm of I.JHlth ymidine inco r-
poration, whereas onl y 10,000 cpm appeared in I-ITL V -111-
infected MT-4 cells on the 5th day- after infection. Thc inhibition 
of cellular DNA synth esis by UV-irradi atcd HTLV-lli in MT-4 
cells is displayed in Fig 38. [3H]Th ymidine uptake was inhibited 
in MT -4 cells infected by HTL V -1Il irradi ated, res pecti ve ly, with 
100 J/m2 , 200 J/m 2 , and 500 J/m2 UV , whereas its inhibition was 
very weak in MT-4 cells infected by 1000 J/m2 and 2000 Jlm 2 
UV-irradiated virus and practica ll y no inhibition was recogni zed 
in th e cells infected by 5000 J/m2 UV-irradiated virus. 
Inactivation of HTL V -III by UV Irradiation Detected by 
Plaque-Forming Assay To attes t th e inactivati on of HTL V-
III by UV irradi ation more distin ctl y, plaqu e-forming assay was 
perform ed (Fig 4, T able I) . Although 100 J/m2 UV-irradiatcd 
virus did no t show a signifi ca nt differen ce compared with unir-
radiated HTLV-III , 2000 J/m2 UV-irradiated HTLV-lII showed 
onl y 1 plaqu e in 3 dishes and 5000 J/ m2 UV-irradiated virus 
showed no plaques: 
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Figtire 4. Plaque-formillg assay with U V-
irradiated and un irradiated control HTL V-III 
in MT-4 cells. The assay was perfo rmed in 
tripli ca te. 
Morphologic Change of the MT -4 Cells Infected by UV-
Irradiated HTLV-III Morph ologic change of MT-4 cell s in-
fected by UV -irradi ated HTL V-III was obscrved as the degen-
eration of ball oonin g w hi ch was a C PE rarely seen in MT-4 cells 
infected by unirradi atcd HTLV-1I1 after 10 days o f culturc. C loned 
HT L V -III (UV-l) was obtained from a plaquc w hich was induced 
by 2000 JIm" UV-irradi ated HTLV-III. Thc clone UV-l also 
induced ballooning in infected MT -4 cells (Fig SA) and this change 
was not shown in MT-4 cells infected by unirradiated HTLV-IIl 
(Fig 58). Thcse balloonin g cell s showed HTL V-Ill viral-specifi c 
antigen which was indistin guishabl e from unirradiated HTL V-
III (Fig 5C, D). 
Resistance to UV of the Cloned HTL V-III Isolated After 
UV Irradiation T o in ves ti ga te wheth er the clone UV -1 has more 
UV resistan ce th an unirradiated HTLV':'m , plaqu e-forming ~ssay 
was perform ed in the sa me mann eLAs shown in T able II, the 
resistance to UV irradiation was not different between clone UV-
1 and unirradiated HTL V-III. 
DISC USSI O N 
Since th e initial reports of AIDS were made in 1981 [1 9,20] the 
number of cases reported each yea r has increased dramati call y. 
C haracteristi call y, AIDS is associated with a progressive depres-
sion of T cell s, es peciall y the helper/ inducer subset bea ring the 
O KT -4 surface marker [21] . It is pl ausible th at the immunode-
fi ciency statu s of patients was induced by HTL V-III infection in 
Table I. Effects of UV Irradiation on HTL V -Ill Infectivity 
Detected by Plaque Formati on in MT-4 Cells 
U V Dose 
O / I11 ~) 
Contro l 
100 
200 
500 
1000 
2000 
5000 
Number o f Plaques per Dish 
105.3 ± 6.0" 
92.7 ± 9.0 
55.3 ± 3.6 
12.0 ± 0.7 
2.0 ± 0.7 
0.3 ± 0.6 
o 
"Expf.:riITI CnrS we re carried o llr in tri plicate. Number represent s the mean :t: SO. 
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Figure 5. Morpho logic change and IF-pos-
itive cells in MT-4 infected by clone UV-l 
and unirradiated HTL V- III/LA V. T he clone 
UV- l was obtained from a plaque fo rmed by 
2000 ]1m 2 UV-irradiated HTLV-III . T he clone 
UV-l induced ballooning degeneration in MT-
4 cells (A, arrow), however these ballooning 
cells were not seen in MT-4 cells infected by 
unirradiated HTLV-III (8). These ballooning 
cells showed the same HTL V -IJI-specific an-
tigens (C) as detec ted in MT-4 cells infec ted 
by un irradiated HTLV- III (D). 
vivo. Al so, the virus was thought to be spread among patients 
w ith hemophilia through the inj ection of facto r VIII concentrate. 
However, an effective therapy has not been found to consistentl y 
treat immunedefi ciency in AIDS. T hus, it is urgent to develop 
cl ini cal or biologic m ethods not on ly for cure but also for inac-
ti vat ion of the vi ru s itself. 
Spire et al [1 31 reported inactivation of LA V by hea t, y-rays, 
and · UV light by measuring reverse transcriptase (RT) ac tivity. 
However, RT ac tivity does not represent the am ount of the virus, 
especiall y in term s o f biologic ac ti vity o f the virus. In view of 
the fac t that even a single in fectio us virion ca n multiply to several 
magnitudes and increase the amount of viru s in the infected cells 
if the a·ppro priate circumstances arc provided , it is most important 
to have a way to meas ure residual viral activity accurately after 
the physical or chemi ca l treatment of the blood prod ucts . Re-
centl y, we also reported that HTL V -III w as inactivated by heatin g 
to 56°C for 30 min , usin g qu antitati ve methods such as pro li f-
eration assay and the virus-specific anti gen induction of the in-
fected MT-4 cel ls rI4] . In the present study, we have attempted 
to evaluate tlie effect of UV irradiation on the infectivity of HTLV-
1JJ by these bioassay methods. 
Our results indi cate th at UV has a dose-dependent inhibitory 
effect on HTLV-:-III infection in MT-4 cells and infectivity of 
HTLV-III was completel y abolished by 5000 J / m2 o f UV irra-
Table II. Comparison of UV Sensitivi ty Between 
HTL V - III/LA V and C lone UV -1 Detected 
Contro l 
500 
1000 
2000 
by Plaque Formation 
Num ber of Plaques per Dish 
HTLV-III 
49.0 ± 12.0" 
11.0±S.2 
3.0 ± 0 
0.7 ± 1. 2 
C lone UV-1 
23.0 ± 2.0" 
3.7 ± 2. 1 
2.3 ± 0.6 
2.3 ± 1.2 
"Experiments were ca rried o ut in triplicate. Number represents the mea n ± SD. 
T I-IE JOURNA L OF IN VESTIG ATIVE DERMATOLOGY 
di ation . The resul ts reported (Fig 1) were li mited to measuring 
at the most a 2 log ki ll of th e AIDS virus. Moreover, Fig 3 shows 
that at least 1/625 of the virus was also killed by th e 5000 J / I11~ 
of UV . Our data roughl y match a previ ous repo rt by Spi re et al 
[1 3]. T hese res ul ts sugges t that UV irrad iati on is a simple and 
useful method to inactivate HTL V-III. 
Furthermore, we noticed that 2000 J / m 2 UV -irradiated H TL V-
1/1 , clone UV-I, induced quite an interesting m o rpho logic change 
\Yhi ch was very rare ly seen w hen MT -4 cell s were infected by a 
control virus. Two possibilities about th is UV -i rradiated HTL V-
III-induced mo rph ologic change were considered: (1) UV irra-
diation induced th e mutation of the virus itself. It is well known 
that UV and oth er kinds of radioactivity induce nucleic acid de-
generation and/o r muta tion of viruses \"22J. (2) UV irradiati on 
simpl y selected a cloned virus with such unusual activity, since 
HTLV-1I1 were isolated fro m the blood pool of severa l AIDS 
patients and genom ic diversity between HTLV-I/I iso lates was 
noted \"23,24]. If UV irradiation might generate mutants of HTLV-
III , an alternative sterili zation method w hi ch is lethal but not 
m utageni c m ay be preferable, especia ll y for blood products. 
However, UV irradi ation is still a simple and useful meth od to 
inactivate HTL V-III /L A V. 
Finall y, blood produ cts are now screened by enzyme-linked 
immunosorbent assay (ELISA) to detect antibodies against HTL V-
III /LA V. However, it remains important to discove r means for 
inactiv ation of HTLV-IIIILAV before they arc adm inistered to 
patien ts, because some pati en ts or individuals have no antibody 
to HTLV-III / LAV bu t have th e virus in their sera r25,26]. M ore-
over, o ur bioassay system should be useful in future studies to 
quantitate the effects of o th er inactivatin g agents o r antiviral dru gs 
on HTLV-III /LAV. 
T he all th or wishes to thallk Ms. Koya llas i ji)r her (/ssista ll ce. 
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